Connection

Emily Adams to Research Design

This is a "connection" page, showing publications Emily Adams has written about Research Design.
Connection Strength

0.035
  1. Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study. J Antimicrob Chemother. 2021 11 12; 76(12):3286-3295.
    View in: PubMed
    Score: 0.018
  2. Prospective observational study of SARS-CoV-2 infection, transmission and immunity in a cohort of households in Liverpool City Region, UK (COVID-LIV): a study protocol. BMJ Open. 2021 03 17; 11(3):e048317.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.